{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-002114","form_type":"8-K","ticker":"MD","cik":"0000893949","company_name":"Pediatrix Medical Group, Inc.","filed_at":"2022-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:10.207980+00:00","generated_at":"2026-06-27T04:28:31.643828+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Mednax President of Pediatrix and Obstetrix Medical Group Roger Mack Hinson to step down effective June 1, 2022","bullets":["Dr. Hinson will transition from his role as President effective June 1, 2022.","Termination is without 'Cause' under his Amended and Restated Employment Agreement.","Company and Dr. Hinson intend to enter a consulting agreement for advisory services post-transition.","No replacement for the President role has been announced."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-002114","json":"https://secwatch.observer/filing/0000950170-22-002114.json","markdown":"https://secwatch.observer/filing/0000950170-22-002114.md","text":"https://secwatch.observer/filing/0000950170-22-002114.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/0000950170-22-002114-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/md-20220223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:28:31.643828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ee90187d53","claim":"Roger Mack Hinson changed role as President of the Company’s Pediatrix and Obstetrix Medical Group at Pediatrix Medical Group, Inc..","evidence_excerpt":"On February 23, 2022, Mednax, Inc., a Florida corporation (the “Company”), announced that Roger Mack Hinson, M.D., President of the Company’s Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/893949/000095017022002114/0000950170-22-002114-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"President of the Company’s Pediatrix and Obstetrix Medical Group"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}